Relevant Articles About Basal Cell Cancer Research (BCC) and Clinical Trials
Trusted insights straight to your inbox and get the latest updates from OncWeekly
KEY TAKEAWAYS The DEEPER phase 2 trial aimed to assess the efficacy of m-FOLFOXIRI + cet in pts with mutant mCRC. The primary endpoint was to determine DpR. The m-FOLFOXIRI + cet had shorter PFS than m-FOLFOXIRI + bev; DpR was similar. The randomized trial has...
KEY TAKEAWAYS The REVERT Interventional trial aimed to enhance clinical decision-making using ML algorithms. AI and ML can optimize mCRC treatment through tailored strategies, enhancing precision and efficacy. Metastatic colorectal cancer (mCRC) presents complex...
KEY TAKEAWAYS The TASKIN phase 1/2 trial aimed to determine the efficacy of TA-102 with XB2001 for patients with mCRC. The primary endpoints were safety and tolerability. FTD-TPI plus XB2001 and bevacizumab demonstrated promising safety profiles and efficacy in...
Background Lung metastasis is the primary cause of breast cancer-related mortality. Neutrophil extracellular traps (NETs) are involved in the progression of breast cancer. However, the mechanism of NET formation is not fully understood. This study posits …
Background The majority of anti-programmed cell-death 1 (PD-1) monoclonal antibodies (mAbs) use S228P mutation IgG4 as the structural basis to avoid the activation of immune cells or complement. However, little attention has been paid to the …
Background Despite continuous improvements in the new target and construction of chimeric antigen receptor (CAR)-T, relapse remains a significant challenge following CAR-T therapy. Tumor microenvironment (TME) strongly correlates with the efficacy of CAR-T therapy. V-domain Ig …
A 62-year-old female patient presented to Chang Gung Memorial Hospital (Taoyuan, Taiwan) in November, 2023, with a 2-week history of painful annular skin rash on both legs. She had been diagnosed with rectal cancer (clinal …